Questions and answers: what can be said by diagnostic imaging in neuroendocrine tumors?

被引：0

作者：

Cuccurullo, V. ^{[1
]}

Faggiano, A. ^{[2
]}

Scialpi, M. ^{[3
]}

Cascini, G. L. ^{[4
]}

Piunno, A. ^{[2
]}

Catalano, O. ^{[5
]}

Colao, A. ^{[2
]}

Mansi, L. ^{[1
]}

机构：

[1] Univ Naples 2, Dept Nucl Med, I-80138 Naples, Italy

[2] Univ Naples Federico II, Dept Endocrinol & Mol Clin Oncol, Naples, Italy

[3] Univ Perugia, Dept Surg Radiol & Odontostomatol Sci, S Maria della Misericordia Hosp, I-06100 Perugia, Italy

[4] Magna Graecia Univ Catanzaro, Dept Nucl Med, Catanzaro, Italy

[5] Fdn G Pascale, Radiodiagnost Operat Unit, Ist Nazl Tumori, Naples, Italy

来源：

MINERVA ENDOCRINOLOGICA | 2012年 / 37卷 / 04期

关键词：

Neuroendocrine tumors; Diagnostic imaging; Radiology; Nuclear medicine; ENETS CONSENSUS GUIDELINES; NUCLEAR-MEDICINE; FOLLOW-UP; EXPERIENCE; MANAGEMENT; STANDARDS; THERAPY; IMAGES; CARE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The neuroendocrine tumors (NET) of the gastro-entero-pancreatic area (GEP) represent a heterogeneous group of malignancies from the histologic, clinico-laboratoristic (functioning and non-functioning variants), and therapeutic point of view. It is an issue becoming more frequent for the diagnostic imager, being radiologist as well as nuclear physician. Imaging (together with biopsy) plays a key role in the diagnostic assessment and staging (including grading and prognostic definition), in evaluating response to treatment, and in follow-up of GEP-NET. Multislice computed tomography (MSCT), octreoscan and PET-CT are the most widely diffuse and accurate imaging modalities employed in this setting. Other methods, such as Magnetic Resonance and Endoscopic Ultrasound, may also play a significant role.

引用

页码：367 / 377

页数：11

共 52 条

[1]

Ambrosini V, 2010, Q J NUCL MED MOL IM, V54, P16

[2] MDCT Evaluation of the Pancreas: Nuts and Bolts [J].

Bashir, Mustafa R. ;

Gupta, Rajan T. .

RADIOLOGIC CLINICS OF NORTH AMERICA, 2012, 50 (03) :365-+

[3]

Basu S, 2008, MINERVA ENDOCRINOL, V33, P257

[4]

Berritto D, 2011, RADIOL MED, V116, P829, DOI 10.1007/s11547-011-0676-7

[5]

Bhate K, 2010, MINERVA ENDOCRINOL, V35, P17

[6] Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET [J].

Binderup, Tina ;

Knigge, Ulrich ;

Loft, Annika ;

Mortensen, Jann ;

Pfeifer, Andreas ;

Federspiel, Birgitte ;

Hansen, Carsten Palnaes ;

Hojgaard, Liselotte ;

Kjaer, Andreas .

JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (05) :704-712

[7] 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging [J].

Bombardieri, Emilio ;

Ambrosini, Valentina ;

Aktolun, Cumali ;

Baum, Richard P. ;

Bishof-Delaloye, Angelica ;

Del Vecchio, Silvana ;

Maffioli, Lorenzo ;

Mortelmans, Luc ;

Oyen, Wim ;

Pepe, Giovanna ;

Chiti, Arturo .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) :1441-1448

[8] Standard Imaging Techniques for Neuroendocrine Tumors [J].

Bushnell, David L. ;

Baum, Richard P. .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (01) :153-+

[9]

Cascini GL, 2010, Q J NUCL MED MOL IM, V54, P24

[10]

Cascini GL, 2010, NUCL MED REV, V13, P32

← 1 2 3 4 5 6 →